Title |
Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation
|
---|---|
Published in |
Journal of Neuroinflammation, March 2013
|
DOI | 10.1186/1742-2094-10-41 |
Pubmed ID | |
Authors |
Celina Wu, Soo Y Leong, Craig S Moore, Qiao Ling Cui, Pavel Gris, Louis-Philippe Bernier, Trina A Johnson, Philippe Séguéla, Timothy E Kennedy, Amit Bar-Or, Jack P Antel |
Abstract |
FTY720 (fingolimod, Gilenya) is a daily oral therapy for multiple sclerosis that readily accesses the central nervous system (CNS). FTY720 is a structural analog to the sphingolipid sphingosine-1-phosphate (S1P) and is a cognate ligand for the S1P G-protein coupled receptors (S1PR). Studies in experimental autoimmune encephalomyelitis using mice with conditionally deleted S1P1R from astrocytes indicate that one beneficial effect of FTY720 in this model is via downregulating external receptors, which inhibits responses induced by the natural ligand. Another proposed effect of FTY720 on neuroinflammation is its ability to maintain persistent signaling in cells via internalized S1P1R resulting in functional responses that include suppressing intracellular calcium release. We used human fetal astrocytes to investigate potential dual inhibitory- and function-inducing effects of daily FTY720 on responses relevant to neuroinflammation. For the inhibitory effects, we used signaling and proliferation induced by the natural ligand S1P. For the function-inducing responses, we measured inhibition of intracellular calcium release stimulated by the proinflammatory cytokine, interleukin (IL)-1β. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Portugal | 1 | 2% |
Brazil | 1 | 2% |
Unknown | 55 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 18 | 32% |
Student > Ph. D. Student | 10 | 18% |
Other | 5 | 9% |
Student > Master | 5 | 9% |
Professor > Associate Professor | 4 | 7% |
Other | 8 | 14% |
Unknown | 7 | 12% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 21% |
Agricultural and Biological Sciences | 12 | 21% |
Neuroscience | 11 | 19% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 7% |
Biochemistry, Genetics and Molecular Biology | 2 | 4% |
Other | 6 | 11% |
Unknown | 10 | 18% |